{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"24.880","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"872,111,470","primaryexch":"香港交易所","ric":"0013.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0441,"inline_upper_strike_price":"","sedol":"BNTDT81","am":"131.12","iv":"","ew_strike":"","as":"24.560","geographic_focus":null,"incorpin":"開曼群島","etp_baseCur":null,"ew_amt_os":"","bd":"24.540","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-09-28 00:06:03.0","lo52":"18.360","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"艾樂德","underlying_ric":"0013.HK","hi52":"34.800","issuer_name":"和黃醫藥（中國）有限公司","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"24.160","mkt_cap":"21.40","f_aum_hkd":null,"ew_sub_per_to":"","ls":"24.540","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-0.400","aum":"","issued_shares_class_B":null,"vo":"5.33","secondary_listing_flag":false,"listing_date":"2021年6月30日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"和黃醫藥（中國）有限公司","nm_s":"和黃醫藥","sym":"13","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.020","strike_price":"","summary":"和黃醫藥（中國）有限公司是一間主要從事製造及銷售藥物的投資控股公司。該公司主要通過兩個分部運營業務。腫瘤免疫業務分部從事發現、開發和商業化用於治療癌症和免疫性疾病的靶向療法和免疫療法。其中研發包括涵蓋藥物發現、開發、生產及監管職能的研發活動，上市產品包括通過研發活動開發的藥物的已開具發票的銷售、推廣、生產及分銷。其他業務分部從事其他商業化業務，包括其他處方藥物及保健品的銷售、推廣、生產及分銷。","op":"24.700","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"藥品","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"香港<br/>九龍紅磡<br/>都會道10號<br/>都會大廈18樓","pc":"-1.60","days_to_expiry":null,"underlying_code":null,"pe":"71.90","eps_ccy":"USD","hdr":false,"launch_date":"","hc":"24.940","isin":"KYG4672N1198","moneyness":""}},"qid":"1759074124743"}
